Anu's Laboratories has achieved impressive performance during the year ended March 2008 and its net profit went up by 33 per cent to Rs 18.07 crore from Rs 13.59 crore in the previous year. Its net sales increased by 41.4 per cent to Rs 154.39 crore from Rs 109.17 crore. After considering the rise in equity capital, the earning per share worked out to Rs 21.89 as compared to Rs 17.04 in the last year. The company declared equity dividend of 15 per cent.

As at the end of 2007-08, its equity capital was at Rs 8.26 crore and same was increased to Rs 12.08 crore through IPO during May 2008. It raised about Rs 80.22 crore through sales of 38.20 lakh shares in its initial public offering to finance its expansion activities.

Hari Babu, managing director, said, "The current set of numbers is consistent with our expectations and from here on our focus will be growth through CRAMS."

Anu's Lab is planning to utilise the IPO proceedings in order to diversify and expand its business activities by means of forward integration. The company plans to expand its operations in CRAM by setting up a new plant for manufacturing of drug intermediates including APIs at Vishakhapatnam. The IPO was oversubscribed by 8.43 times.